{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:28:23Z","timestamp":1793089703901,"version":"4.5.0"},"reference-count":162,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.hoc.2009.04.004","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T05:35:30Z","timestamp":1246599330000},"page":"791-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma"],"prefix":"10.1016","volume":"23","author":[{"given":"Laurence","family":"de Leval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Paul","family":"Hasserjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hoc.2009.04.004_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0609.1998.tb01023.x","article-title":"Diffuse large B-cell lymphoma: is morphologic subdivision useful in clinical management?","volume":"60","author":"Fernandez de Sevilla","year":"1998","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/10428190210173","article-title":"Diffuse large B-cell lymphoma: a clinicopathologic analysis of 444 cases classified according to the updated Kiel classification","volume":"43","author":"Diebold","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V79.4.1024.bloodjournal7941024","article-title":"Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma","volume":"79","author":"Cabanillas","year":"1992","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib4","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.LAB.0000050762.61660.27","article-title":"Discordant bone marrow involvement in diffuse large B-cell lymphoma: comparative molecular analysis reveals a heterogeneous group of disorders","volume":"83","author":"Kremer","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.hoc.2009.04.004_bib5","first-page":"611","article-title":"Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression","volume":"5","author":"Davis","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.hoc.2009.04.004_bib6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood.V99.3.815","article-title":"De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients","volume":"99","author":"Yamaguchi","year":"2002","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib7","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/annonc\/mdn392","article-title":"CD5 expression is potentially predictive of poor outcome among biomarkers in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP therapy","volume":"19","author":"Ennishi","year":"2008","journal-title":"Ann Oncol"},{"issue":"20","key":"10.1016\/j.hoc.2009.04.004_bib8","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.hoc.2009.04.004_bib9","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1200\/JCO.2004.11.025","article-title":"Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas","volume":"22","author":"Bea","year":"2004","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0037-1963(00)90019-2","article-title":"Recurring chromosomal abnormalities in non-Hodgkin's lymphoma: biologic and clinical significance","volume":"37","author":"Chaganti","year":"2000","journal-title":"Semin Hematol"},{"issue":"6844","key":"10.1016\/j.hoc.2009.04.004_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/35085588","article-title":"Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas","volume":"412","author":"Pasqualucci","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.hoc.2009.04.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1040-8428(01)00164-0","article-title":"Regulation of gene expression by the proto-oncogene BCL-6","volume":"41","author":"Dent","year":"2002","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7017","key":"10.1016\/j.hoc.2009.04.004_bib13","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib14","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V83.9.2423.2423","article-title":"LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients","volume":"83","author":"Bastard","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.hoc.2009.04.004_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1365-2141.2002.03435.x","article-title":"Rearrangement of the BCL6 locus at 3q27 is an independent poor prognostic factor in nodal diffuse large B-cell lymphoma","volume":"117","author":"Barrans","year":"2002","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","article-title":"Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)","volume":"87","author":"Hermine","year":"1996","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib17","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V90.1.244","article-title":"Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma","volume":"90","author":"Gascoyne","year":"1997","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib18","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1182\/blood-2002-11-3387","article-title":"Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma","volume":"101","author":"Pasqualucci","year":"2003","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib19","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/blood-2008-01-129783","article-title":"Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study","volume":"112","author":"Young","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib20","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1182\/blood-2003-04-1359","article-title":"Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas","volume":"103","author":"Houldsworth","year":"2004","journal-title":"Blood"},{"issue":"6769","key":"10.1016\/j.hoc.2009.04.004_bib21","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.hoc.2009.04.004_bib22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.hoc.2009.04.004_bib23","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.hoc.2009.04.004_bib24","doi-asserted-by":"crossref","first-page":"10209","DOI":"10.1073\/pnas.180316097","article-title":"Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas","volume":"97","author":"Lossos","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib25","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1038\/sj.leu.2404856","article-title":"Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma","volume":"21","author":"Iqbal","year":"2007","journal-title":"Leukemia"},{"issue":"7089","key":"10.1016\/j.hoc.2009.04.004_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.hoc.2009.04.004_bib27","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.hoc.2009.04.004_bib28","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1056\/NEJMoa032520","article-title":"Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes","volume":"350","author":"Lossos","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib29","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1182\/blood-2008-02-137372","article-title":"Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP","volume":"112","author":"Rimsza","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib31","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1200\/JCO.2006.09.4490","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications\u2013a study from the Lunenburg Lymphoma Biomarker Consortium","volume":"25","author":"de Jong","year":"2007","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1182\/blood.V99.4.1136","article-title":"Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma","volume":"99","author":"Barrans","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib33","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00000478-200404000-00005","article-title":"Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma","volume":"28","author":"Chang","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1182\/blood-2002-04-1286","article-title":"Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma","volume":"101","author":"Colomo","year":"2003","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.hoc.2009.04.004_bib35","doi-asserted-by":"crossref","first-page":"7060","DOI":"10.1200\/JCO.2005.15.503","article-title":"Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas","volume":"23","author":"De Paepe","year":"2005","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib36","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","article-title":"Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy","volume":"109","author":"Nyman","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2559.2003.01758.x","article-title":"Variability in immunophenotype in diffuse large B-cell lymphoma and its clinical relevance","volume":"43","author":"de Leval","year":"2003","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib38","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2005.02.4786","article-title":"Prognostic biomarkers in diffuse large B-cell lymphoma","volume":"24","author":"Lossos","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib39","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib40","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1158\/1078-0432.1065.11.3","article-title":"Expression of the FOXP1 transcription factor is strongly associated with inferior survival in patients with diffuse large B-cell lymphoma","volume":"11","author":"Banham","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JCO.2007.13.0690","article-title":"LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab","volume":"26","author":"Natkunam","year":"2008","journal-title":"J Clin Oncol"},{"issue":"25","key":"10.1016\/j.hoc.2009.04.004_bib42","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1038\/sj.onc.1210376","article-title":"Rituximab therapy in malignant lymphoma","volume":"26","author":"Coiffier","year":"2007","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib43","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00000478-200307000-00005","article-title":"Micronodular T-cell\/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis","volume":"27","author":"Dogan","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib44","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/00000478-200211000-00008","article-title":"T-cell\/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells","volume":"26","author":"Lim","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib45","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2559.2002.01291.x","article-title":"Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features","volume":"40","author":"Achten","year":"2002","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib46","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1097\/00000478-199810000-00003","article-title":"Differential diagnosis between classic Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and paragranuloma by paraffin immunohistochemistry","volume":"22","author":"Rudiger","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib47","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma","volume":"32","author":"Nam-Cha","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib48","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.hoc.2009.04.004_bib49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workshop on the relationship between nodular lymphocyte predominant Hodgkin's lymphoma and T cell\/histiocyte-rich B cell lymphoma","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib50","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0002-9440(10)64462-8","article-title":"Comparative genomic hybridization pattern distinguishes T-cell\/histiocyte-rich B-cell lymphoma from nodular lymphocyte predominance Hodgkin's lymphoma","volume":"161","author":"Franke","year":"2002","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib51","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1023\/A:1011195708834","article-title":"Among diffuse large B-cell lymphomas, T-cell-rich\/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features","volume":"12","author":"Maes","year":"2001","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib52","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2003.06.046","article-title":"T-cell\/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis","volume":"21","author":"Bouabdallah","year":"2003","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib53","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.2005.04.8819","article-title":"Primary CNS lymphoma","volume":"24","author":"Batchelor","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib54","first-page":"1063","article-title":"BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma","volume":"9","author":"Braaten","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib55","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1182\/blood-2005-03-1024","article-title":"A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases","volume":"107","author":"Camilleri-Broet","year":"2006","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib56","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2008-04-149005","article-title":"Primary lymphoma of the central nervous system: just DLBCL or not?","volume":"113","author":"Montesinos-Rongen","year":"2009","journal-title":"Blood"},{"issue":"29","key":"10.1016\/j.hoc.2009.04.004_bib57","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1200\/JCO.2008.16.1455","article-title":"Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course","volume":"26","author":"Cady","year":"2008","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib58","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1182\/blood-2005-03-0897","article-title":"Gene expression and angiotropism in primary CNS lymphoma","volume":"107","author":"Rubenstein","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib59","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.leu.2405019","article-title":"Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell","volume":"22","author":"Montesinos-Rongen","year":"2008","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib60","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1182\/blood-2007-10-119099","article-title":"Pathway analysis of primary central nervous system lymphoma","volume":"111","author":"Tun","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib61","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1182\/blood-2005-08-3443","article-title":"Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID","volume":"107","author":"Dijkman","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib62","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib63","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"issue":"17","key":"10.1016\/j.hoc.2009.04.004_bib64","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3960\/jslrt.46.1","article-title":"Senile Epstein-Barr virus-associated B-cell lymphoproliferative disorders: a mini review","volume":"46","author":"Shimoyama","year":"2006","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib66","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","article-title":"The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma","volume":"110","author":"Park","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib67","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2559.1986.tb02491.x","article-title":"Large cell lymphoma of the mediastinum: a B-cell tumour of probable thymic origin","volume":"10","author":"Addis","year":"1986","journal-title":"Histopathology"},{"key":"10.1016\/j.hoc.2009.04.004_bib68","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/S0140-6736(87)92622-5","article-title":"The human thymus contains a novel population of B-lymphocytes","volume":"ii","author":"Isaacson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.hoc.2009.04.004_bib69","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/1097-0142(19881101)62:9<1893::AID-CNCR2820620904>3.0.CO;2-X","article-title":"Mediastinal large cell lymphoma: an uncommon subset of adult lymphoma curable with combined modality therapy","volume":"62","author":"Jacobson","year":"1988","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib70","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d'Etude des Lymphomes de l'Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib71","first-page":"187","article-title":"Primary mediastinal large B-cell lymphoma with sclerosis: a clinical study of 89 patients treated with MACOP-B chemotherapy and radiation therapy","volume":"86","author":"Zinzani","year":"2001","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib72","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib73","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/00000478-198909000-00002","article-title":"Primary large cell lymphoma of the mediastinum. A histologic and immunophenotypic study of 29 cases","volume":"13","author":"Lamarre","year":"1989","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib74","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","article-title":"Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins","volume":"162","author":"Pileri","year":"2003","journal-title":"Am J Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib75","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00000478-200110000-00008","article-title":"Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells?","volume":"25","author":"de Leval","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib76","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2559.2004.01969.x","article-title":"CD23 expression in mediastinal large B-cell lymphomas","volume":"45","author":"Calaminici","year":"2004","journal-title":"Histopathology"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib77","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib78","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1182\/blood-2002-07-2215","article-title":"Interleukin 4-induced gene 1\u00a0is activated in primary mediastinal large B-cell lymphoma","volume":"101","author":"Copie-Bergman","year":"2003","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib79","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin's lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib80","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.pas.0000213334.40358.0e","article-title":"Expression of TRAF1 and nuclear c-Rel distinguishes primary mediastinal large cell lymphoma from other types of diffuse large B-cell lymphoma","volume":"31","author":"Rodig","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib81","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood.V98.9.2762","article-title":"Isotype-switched immunoglobulin genes with a high load of somatic hypermutation and lack of ongoing mutational activity are prevalent in mediastinal B-cell lymphoma","volume":"98","author":"Leithauser","year":"2001","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib82","first-page":"2017","article-title":"Molecular characterization of primary mediastinal B cell lymphoma","volume":"148","author":"Tsang","year":"1996","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib83","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib84","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":"Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","article-title":"Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2","volume":"103","author":"Joos","year":"2003","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib86","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NF{kappa}B activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib87","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":"Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib88","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.hoc.2009.04.004_bib89","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","article-title":"Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation","volume":"25","author":"Weniger","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib90","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.leu.2404594","article-title":"High expression of several tyrosine kinases and activation of the PI3K\/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma","volume":"21","author":"Renne","year":"2007","journal-title":"Leukemia"},{"issue":"Suppl 5","key":"10.1016\/j.hoc.2009.04.004_bib91","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1093\/annonc\/9.suppl_5.S31","article-title":"Workshop report on Hodgkin's disease and related diseases (\u2018grey zone\u2019 lymphoma)","volume":"9","author":"Rudiger","year":"1998","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib92","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib93","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/01.pap.0000138144.11635.f8","article-title":"Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma","volume":"11","author":"Calvo","year":"2004","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib94","first-page":"826","article-title":"An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome","volume":"111","author":"Murase","year":"2000","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib95","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2141.2008.07338.x","article-title":"The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in \u2018Western\u2019 patients with intravascular large B-cell lymphoma","volume":"143","author":"Ferreri","year":"2008","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib96","first-page":"983","article-title":"Intravascular large B-cell lymphoma: the CD5 antigen is expressed by a subset of cases","volume":"11","author":"Khalidi","year":"1998","journal-title":"Mod Pathol"},{"issue":"21","key":"10.1016\/j.hoc.2009.04.004_bib97","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1200\/JCO.2006.08.2313","article-title":"Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting","volume":"25","author":"Ponzoni","year":"2007","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib98","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2004.05177.x","article-title":"Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the \u2018cutaneous variant\u2019","volume":"127","author":"Ferreri","year":"2004","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib99","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/modpathol.3880450","article-title":"Angiotropic lymphoma: an immunophenotypically and clinically heterogeneous lymphoma","volume":"14","author":"Yegappan","year":"2001","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib100","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0046-8177(00)80223-3","article-title":"Lack of CD 29 (beta1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis","volume":"31","author":"Ponzoni","year":"2000","journal-title":"Hum Pathol"},{"issue":"20","key":"10.1016\/j.hoc.2009.04.004_bib101","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1200\/JCO.2002.09.021","article-title":"Pyothorax-associated lymphoma: a review of 106 cases","volume":"20","author":"Nakatsuka","year":"2002","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib102","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00000478-200206000-00005","article-title":"Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B-and T-cell phenotype","volume":"26","author":"Petitjean","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib103","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1440-1827.1998.tb03966.x","article-title":"Mechanism for the development of pyothorax-associated lymphoma","volume":"48","author":"Kanno","year":"1998","journal-title":"Pathol Int"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib104","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2559.2001.01197.x","article-title":"Evidence for local immunosuppression and demonstration of c-myc amplification in pyothorax-associated lymphoma","volume":"39","author":"Yamato","year":"2001","journal-title":"Histopathology"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib105","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1349-7006.2004.tb02189.x","article-title":"Distinct pattern of gene expression in pyothorax-associated lymphoma (PAL), a lymphoma developing in long-standing inflammation","volume":"95","author":"Nishiu","year":"2004","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib106","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.leu.2405059","article-title":"Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein-Barr virus infection","volume":"22","author":"Takakuwa","year":"2008","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<287::AID-PATH932>3.0.CO;2-Q","article-title":"Epstein-Barr virus in B-cell lymphomas associated with chronic suppurative inflammation","volume":"183","author":"Copie-Bergman","year":"1997","journal-title":"J Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib108","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/01.pas.0000157747.10967.f4","article-title":"Metallic implant-associated lymphoma: a distinct subgroup of large B-cell lymphoma related to pyothorax-associated lymphoma?","volume":"29","author":"Cheuk","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib109","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00000478-199408000-00001","article-title":"Pulmonary lymphomatoid granulomatosis. Evidence for a proliferation of Epstein-Barr virus infected B-lymphocytes with a prominent T-cell component and vasculitis","volume":"18","author":"Guinee","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2009.04.004_bib110","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00000478-200109000-00001","article-title":"Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features","volume":"25","author":"Beaty","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib111","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s00428-002-0694-x","article-title":"Posttransplant diffuse large B-cell lymphoma of \u201clymphomatoid granulomatosis\u201d type","volume":"441","author":"Saxena","year":"2002","journal-title":"Virchows Arch"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib112","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00000478-199511000-00011","article-title":"Lymphomatoid granulomatosis. Evidence of immunophenotypic diversity and relationship to Epstein-Barr virus infection","volume":"19","author":"Myers","year":"1995","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib113","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib114","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","article-title":"Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities","volume":"28","author":"Colomo","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib115","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","article-title":"CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogeneous spectrum in both HIV-positive and -negative patients","volume":"15","author":"Teruya-Feldstein","year":"2004","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib116","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1097\/01.pas.0000173023.02724.1f","article-title":"Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr Virus-associated extramedullary plasmacytic neoplasm","volume":"29","author":"Dong","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.hoc.2009.04.004_bib117","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib118","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega","year":"2005","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib119","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","article-title":"A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation","volume":"89","author":"Delsol","year":"1997","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib120","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2003-03-0786","article-title":"ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases","volume":"102","author":"Gascoyne","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib121","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2003-04-1095","article-title":"ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases","volume":"102","author":"Onciu","year":"2003","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.hoc.2009.04.004_bib122","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib123","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1182\/blood.V90.3.1186.1186_1186_1191","article-title":"Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus\/human herpesvirus-8","volume":"90","author":"Horenstein","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib124","first-page":"4894","article-title":"Association of Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma with expression of the CD138\/syndecan-1 antigen","volume":"90","author":"Gaidano","year":"1997","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.hoc.2009.04.004_bib125","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.1630810100","article-title":"Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile","volume":"100","author":"Jenner","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib126","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","article-title":"Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.hoc.2009.04.004_bib127","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","article-title":"Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS","volume":"23","author":"Boulanger","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib128","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib129","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","article-title":"HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma","volume":"95","author":"Dupin","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib130","first-page":"15","article-title":"Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. The French Study Group of Pathology for Human Immunodeficiency Virus-Associated Tumors","volume":"115","author":"Raphael","year":"1991","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib131","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403847","article-title":"Molecular heterogeneity of sporadic adult Burkitt-type leukemia\/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features","volume":"19","author":"Burmeister","year":"2005","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.hoc.2009.04.004_bib132","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1200\/JCO.2000.18.21.3707","article-title":"Molecular biology of Burkitt's lymphoma","volume":"18","author":"Hecht","year":"2000","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib133","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood.V63.5.1102.1102","article-title":"An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults","volume":"63","author":"Magrath","year":"1984","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.hoc.2009.04.004_bib134","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hoc.2009.04.004_bib135","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/00000478-200006000-00010","article-title":"CD10 and bcl-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas","volume":"24","author":"Dogan","year":"2000","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib136","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/PAS.0b013e3180959e09","article-title":"Characteristic expression patterns of TCL1, CD38, and CD44 identify aggressive lymphomas harboring a MYC translocation","volume":"32","author":"Rodig","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib137","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1309\/EQJR3D3V0CCQGP04","article-title":"Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH","volume":"128","author":"Chuang","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"33","key":"10.1016\/j.hoc.2009.04.004_bib138","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib139","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrmicro1089","article-title":"Endemic Burkitt's lymphoma: a polymicrobial disease?","volume":"3","author":"Rochford","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.hoc.2009.04.004_bib140","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cell.2008.09.062","article-title":"AID is required for the chromosomal breaks in c-myc that lead to c-myc\/IgH translocations","volume":"135","author":"Robbiani","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib141","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2005-01-0168","article-title":"Immunoglobulin gene analysis reveals 2\u00a0distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas","volume":"106","author":"Bellan","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib142","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1182\/blood.V77.7.1516.1516","article-title":"Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association","volume":"77","author":"Shiramizu","year":"1991","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib143","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of today's knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.hoc.2009.04.004_bib144","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0065-230X(08)60712-5","article-title":"Molecular pathogenesis of AIDS-related lymphomas","volume":"67","author":"Gaidano","year":"1995","journal-title":"Adv Cancer Res"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib145","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","article-title":"MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation","volume":"216","author":"Leucci","year":"2008","journal-title":"J Pathol"},{"issue":"23","key":"10.1016\/j.hoc.2009.04.004_bib146","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt's lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib147","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.hoc.2009.04.004_bib148","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1349-7006.2007.00681.x","article-title":"High-grade mature B-cell lymphoma with Burkitt-like morphology: results of a clinicopathological study of 72 Japanese patients","volume":"99","author":"Nomura","year":"2008","journal-title":"Cancer Sci"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib149","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib150","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib151","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/annonc\/mdi403","article-title":"Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol","volume":"16","author":"Divine","year":"2005","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib152","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2141.2003.04134.x","article-title":"Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group experience","volume":"120","author":"Cairo","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib153","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V85.3.664.bloodjournal853664","article-title":"Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols","volume":"85","author":"Soussain","year":"1995","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.hoc.2009.04.004_bib154","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2006-07-036673","article-title":"Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients","volume":"109","author":"Patte","year":"2007","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2009.04.004_bib155","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.pas.0000168176.71405.e5","article-title":"Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma","volume":"29","author":"Haralambieva","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.hoc.2009.04.004_bib156","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1097\/01.pas.0000180442.87022.08","article-title":"Adult B-cell lymphomas with Burkitt-like morphology are phenotypically and genotypically heterogeneous with aggressive clinical behavior","volume":"29","author":"McClure","year":"2005","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.hoc.2009.04.004_bib157","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","article-title":"The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement","volume":"92","author":"Le Gouill","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.hoc.2009.04.004_bib158","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/modpathol.3800500","article-title":"Lymphoid neoplasms associated with concurrent t(14;18) and 8q24\/c-MYC translocation generally have a poor prognosis","volume":"19","author":"Kanungo","year":"2006","journal-title":"Mod Pathol"},{"issue":"25","key":"10.1016\/j.hoc.2009.04.004_bib159","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1200\/JCO.2006.05.5897","article-title":"Prognostic impact of germinal center-associated proteins and chromosomal breakpoints in poor-risk diffuse large B-cell lymphoma","volume":"24","author":"van Imhoff","year":"2006","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2009.04.004_bib160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2559.2005.02068.x","article-title":"Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology","volume":"46","author":"Leoncini","year":"2005","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.hoc.2009.04.004_bib161","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.leu.2403661","article-title":"Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas","volume":"19","author":"Knezevich","year":"2005","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.hoc.2009.04.004_bib162","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small noncleaved, non-Burkitt's (Burkitt-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"J Clin Oncol"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880900080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088985880900080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:52:44Z","timestamp":1760183564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088985880900080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":162,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S088985880900080X"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2009.04.004","relation":{},"ISSN":["0889-8588"],"issn-type":[{"value":"0889-8588","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2009.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}